North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 19 of 19
Details
UPD
sitematrix Changed from 0 to
20/11/2023 12:41:57
(DavidS )
UPD
FurtherInformation Changed from
Approved for use in the treatment of renal cell carcinoma in line with NICE and NHS England Commissioning Policy
Approved for the treatment of medullary thyroid cancer in line with NICE and
20/11/2023 12:41:57
(DavidS )
UPD
Cabozantinib (Cometriq
®
) updated formatting
20/11/2023 12:41:57
(DavidS )
UPD
sitematrix Changed from 0 to
11/07/2023 17:18:35
(dmcdermott )
UPD
FurtherInformation Changed from
Approved for use in the treatment of renal cell carcinoma in line with NICE and NHS England Commissioning Policy
Approved for the treatment of medullary thyroid cancer in line with NICE and NHS Eng
11/07/2023 17:18:35
(dmcdermott )
UPD
Cabozantinib (Cometriq
®
) =
11/07/2023 17:18:35
(dmcdermott )
LDL
Link Added : MHRA Drug Safety Update (July 2020): Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection : https://www.gov.uk/drug-safety-update/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-arte
11/07/2023 17:17:57
(dmcdermott )
LDL
Link Added : NICE TA849: Cabozantinib for previously treated advanced hepatocellular carcinoma : https://www.nice.org.uk/guidance/ta849
04/07/2023 12:14:37
(rpaylor )
LDL
Link Added : NICE TA 542: Cabozantinib for untreated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta542
24/01/2019 15:27:23
(DavidS )
UPD
Cabozantinib (Cometriq
®
) NICE TA542
24/01/2019 15:26:43
(DavidS )
UPD
Published from Draft Mode
09/05/2018 10:59:07
(LoweryM )
UPD
Cabozantinib (Cometriq
®
) approved
09/05/2018 10:58:33
(LoweryM )
LDL
Link Added : NICE TA516: Cabozantinib for treating medullary thyroid cancer : https://www.nice.org.uk/guidance/ta516
27/04/2018 14:19:54
(DavidS )
UPD
Cabozantinib (Cometriq
®
) NICE TA516 approved at APC (April 2018)
27/04/2018 14:19:23
(DavidS )
UPD
Published from Draft Mode
27/10/2017 15:02:24
(DavidS )
UPD
Cabozantinib (Cometriq
®
) updated
27/10/2017 15:02:11
(DavidS )
LDL
Link Added : NICE TA463 Cabozantinib for previously treated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta463
26/10/2017 13:36:03
(DavidS )
UPD
Cabozantinib (Cometriq
®
) NICE TA463
26/10/2017 13:16:39
(DavidS )
UPD
Status Changed to | Hidden | Published
22/03/2017 15:10:45
(DavidS )